Vivus Muse TV Ad Female Voice Risk Presentation Cited By FDA
Executive Summary
Vivus' direct-to-consumer television and print ads for its erectile dysfunction therapy Muse are cited for inadequate risk information in a Feb. 19 notice of violation letter from FDA's ad division.